Domov › Steatotické ochorenie pečene › Texas › Austin
Klinické štúdie Steatotické ochorenie pečene v meste Austin, TX
13 štúdií pre Steatotické ochorenie pečene hľadá účastníkov v zariadeniach v meste Austin a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Prebieha náborFáza 3
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Prebieha náborFáza 3
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Prebieha náborFáza 3
- GSK Investigational Site, Austin
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Prebieha náborFáza 3
- GSK Investigational Site, Austin
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Prebieha náborFáza 2
- American Research Corporation, Austin
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Prebieha náborFáza 2
- American Research Corporation, Austin
- Pinnacle Clinical Research - Austin, Austin
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Prebieha náborFáza 3
- IMA Clinical Research Austin, Austin
- American Research Corporation, Austin
- Pinnacle Clinical Research, Austin
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Prebieha náborFáza 3
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Prebieha náborFáza 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Prebieha náborFáza 2
- Pinnacle Clinical Research, Austin
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Prebieha náborFáza 2
- GSK Investigational Site, Austin
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Prebieha náborFáza 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Prebieha náborFáza 2
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
Štúdie Steatotické ochorenie pečene v iných mestách
- San Antonio, TX17 štúdií
- New York City, NY16 štúdií
- Miami, FL16 štúdií
- San Diego, CA14 štúdií
- Houston, TX13 štúdií
- Richmond, VA12 štúdií
- Tucson, AZ10 štúdií
- Chandler, AZ10 štúdií
- Hialeah, FL9 štúdií
- Dallas, TX9 štúdií
- Orlando, FL9 štúdií
- St. Louis, MO9 štúdií
Iné štúdie v Austin
- Nemalobunkový karcinóm pľúc30 štúdií
- Rakovina (všetky typy)20 štúdií
- Obézita20 štúdií
- Kolorektálny karcinóm19 štúdií
- Metastatická rakovina19 štúdií
- Nadváha18 štúdií
- Srdcové zlyhanie18 štúdií
- Rakovina prsníka18 štúdií
- Rakovina vaječníkov17 štúdií
- Rakovina endometria15 štúdií
- Rakovina prostaty15 štúdií
- Depresia14 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.